Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02890329 |
|---|---|
| Brief Title: | Ipilimumab and Decitabine in Treating Patients With Relapsed or Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia |
| First Submitted : | September 1, 2016 |
| First Submitted that Met QC Criteria : | September 1, 2016 |
| First Posted : | September 7, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | March 20, 2024 |
| Last Update Posted : | March 21, 2024 |